News Center
1 week agoOMG science
Drug Reprograms Immune Responses to Target Glioblastoma - News Center
Using a novel drug to target the STING pathway in glioblastoma reprograms immune responses, offering a promising therapeutic strategy for non-responsive patients. [ more ]